Issued: 27 jan 2023 @ 15:39
Previous signal: Jan 27 - 15:31
Return: -0.26 %
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer...
|Today's Volume||169 049T|
|Average Volume||230 855T|